Skip to content

Clinical trials

Terminated Stomach Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Status: Terminated Country / region: United Kingdom Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20113
20123
20142
20151
20182
20192
20203
20211
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
Seagen Inc.3
Hoffmann-La Roche2
Taiho Oncology, Inc.2
ADC Therapeutics S.A.1
AstraZeneca1
Basilea Pharmaceutica1
Blueprint Medicines Corporation1
Cancer Research UK1
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms22
Carcinoma, Non-Small-Cell Lung10
Triple Negative Breast Neoplasms7
Ovarian Neoplasms6
Carcinoma, Renal Cell5
Esophageal Neoplasms5
Melanoma5
Squamous Cell Carcinoma of Head and Neck5
Colorectal Neoplasms4
Endometrial Neoplasms4

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.